I have been giving this a lot of thought lately and the more I think about it the more it makes sense. Now, mind you, this could be said of many small biotech companies, but here are my simple reasons why for IDRA:
1. Relative small number of shares in float (75M or so) 2. So far, excellent Phase 2 results...look it up, many companies with P2 results have been snapped up. 3. Big Pharma companies are lacking drugs in their pipeline and are looking for cancer drugs for their future. 4. Abbott as their first partner is no slouch mid size company, so we are on the radar of Big Pharma, no doubt. 5. Board, management team and new hires are very qualified/smart individuals and a buyout would be a great return on their investment. 6. As Russell Wilson, Seahawks QB, said to his team before last season began "Why not us!" Now please, this is not a prediction, nor do I have a price or timing in mind, again, just a gut feel. Your thoughts?
My thoughts are that IDRA is not wanting to get bought out before they even get started. They have the Executive team in place to grow a Genzyme-like behemoth, why would they want Big Pharma to get in the way of that? The rewards are sweeter when you run your own race. Then you can sell the company when it is worth over $20B , that is what Sanofi paid for Genzyme. IMHO, these executives are here for the long haul to reap the benefits of a company that they build from the ground up. They do not want to answer to Big Pharma politics, they want to call the shots. That is why they left Genzyme when Sanofi acquired them IMO. We are in good hands, just take a breath and watch them grow.
Oh don't get me wrong, I would love the scenario you describe, but Mergers and Acquisitions are up and on the rise and big pharma is looking for gems, IDRA does qualify as a gem. Trust me, I am here for the big payoff, I just have that thing in my gut. I would take $20 now though! Maybe more later, right?